NeuroSense Therapeutics Ltd.

NRSN · XNAS

CIK 1875091fmd_1CWEBJ6G4S568N65AE5ZKTFTF6Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2019 to Dec 31, 2025, 12 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.